Evidence map›Paper›PMID 22002720›Full record

ArticleNature chemical biology2011

N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.

Guifang Jia, Ye Fu, Xu Zhao, Qing Dai, Guanqun Zheng, Ying Yang, Chengqi Yi, Tomas Lindahl, Tao Pan, Yun-Gui Yang and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Nature chemical biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2,518 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,518citing papers in PubMed, 1 pooled it
27.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2,518 citing papers in PubMed, 1 synthesis or guideline pooled it, 4,052 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. NAR cancer · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. The cellular landscape of druggable RNA-binding proteins.Nature reviews. Drug discovery · 2026
    Review
  19. Article
  20. Article

2,458 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Guifang JiaDepartment of Chemistry, University of Chicago, Chicago, Illinois, USA.
Ye Fu
Xu Zhao
Qing Dai
Guanqun Zheng
Ying Yang
Chengqi Yi
Tomas Lindahl
Tao Pan
Yun-Gui Yang
Chuan He
University of Chicago · USChinese Academy of Sciences · CNCancer Research UK · GBUniversity of Chinese Academy of Sciences · CN

Funding

Direct Oxidative Nucleic Acids DemethylationR01GM071440 · NIGMS · UNIVERSITY OF CHICAGO · PI HE, CHUAN · 2005 to 2018
$3.7M
Discovering the epigenetics of RNA modificationsR01GM088599 · NIGMS · UNIVERSITY OF CHICAGO · PI HE, CHUAN, PAN, TAO · 2009 to 2012
$1.2M
NIGMS NIH HHS GM071440NIGMS NIH HHS GM088599NIGMS NIH HHS R01 GM071440NIGMS NIH HHS R01 GM088599
6 · The paper itself

Abstract

We report here that fat mass and obesity-associated protein (FTO) has efficient oxidative demethylation activity targeting the abundant N6-methyladenosine (m(6)A) residues in RNA in vitro. FTO knockdown with siRNA led to increased amounts of m(6)A in mRNA, whereas overexpression of FTO resulted in decreased amounts of m(6)A in human cells. We further show the partial colocalization of FTO with nuclear speckles, which supports the notion that m(6)A in nuclear RNA is a major physiological substrate of FTO.

Indexed as

ObesityAdenosineAlpha-Ketoglutarate-Dependent Dioxygenase FTOCell NucleusHeLa CellsHumansMethylationOxidation-ReductionProteinsRNA, MessengerSubstrate SpecificityAdenosineAlpha-Ketoglutarate-Dependent Dioxygenase FTOFTO protein, humanN-methyladenosineProteinsRNA, Messenger

Identifiers

PMID22002720
PMCPMC3218240
OpenAlexW2071930821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.